Home Resources Therapy Watch expands geographic coverage of the global COVID-19 tracker

Therapy Watch expands geographic coverage of the global COVID-19 tracker

2 mins read
3 August 2023

Since its launch in September 2021, Therapy Watch COVID-19 has been monitoring the ever-changing landscape of the COVID-19 treatment market. We are pleased to share that we have expanded our tracker for 2023 to include Australia, Canada, Japan, and Greece.

With these new additions, we now have a comprehensive coverage of 16 markets: US, Canada, EU5, Greece, Japan, South Korea, Singapore, Australia, Brazil, Mexico, Saudi Arabia, and Morocco.

Online interviews are conducted with a range of specialists and primary care physicians in each market. Through these interviews, we gain valuable insights into COVID-19 patients across the community, ambulatory care, or hospital settings.

By utilizing our tracker, our clients can effectively address crucial questions pertaining to COVID-19 treatment, such as:

  • What is the proportion of COVID-19 patients who receive treatment? How does this vary based on the severity of disease and the patient’s risk of progression?
  • Which factors drive or hinder prescription rates?
  • How does the patient profile differ depending on the prescribed treatment?
  • What is the patient’s treatment journey and the time taken at each stage?

Therapy Watch COVID-19 serves as an invaluable tool in monitoring the ever-evolving treatment landscape. With real-world insights, we are able to uncover the drivers behind COVID-19 prescription in each patient segment and country.

Therapy Watch is a syndicated market tracking tool that provides market researchers and marketing teams and with real-world evidence into prescribing behaviors and market dynamics.

Contact us.

To learn more about our study and how it could help address your business questions.

Sign up to receive Rapport.

Rapport is our monthly newsletter where we share our latest expertise and experience.